Last reviewed · How we verify

NCT06140030

Mindfulness Training in Adolescents With Type 1 Diabetes

Status unknown NA Last updated 7 December 2023
What this trial tests

NA trial testing Mindfulness training in Anxiety in 40 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
1 March 2025
1 December 2025

Quick facts

Lead sponsorUniversity of South Florida
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 October 2023
Primary completion1 March 2025
Estimated completion1 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of South Florida

Who can join

Adults 12 to 19, any sex, with Anxiety or Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Creation of an adaptation of a mindfulness-based stress reduction mobile health application specifically designed for adolescents living with Type 1 diabetes. Aim to determine whether daily mindfulness improves anxiety symptoms in adolescents with Type 1 diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Mindfulness training

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other University of South Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06140030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing